Completed NA INTERVENTIONAL 2-arm NCT05224947

Gastric Layering and Monitoring II (GLAM-II)

Sponsor: FrieslandCampina

Updated 5 times since 2022 Last updated: Mar 28, 2024 Started: Jan 28, 2022 Primary completion: Apr 22, 2022 Completion: Apr 22, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Infant Formula and is currently completed. FrieslandCampina leads this study, which shows 5 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
May 2024 — Jul 2024 [monthly]

Completed NA
Jun 2023 — May 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Mar 2022 — Jun 2023 [monthly]

Recruiting NA

First recorded

Jan 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

FrieslandCampina
Wageningen University

Data source: Wageningen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Wageningen, Netherlands